CymitQuimica logo
MAPK

MAPK

Le MAPK sono una famiglia di chinasi proteiche coinvolte in una varietà di processi cellulari, tra cui crescita, proliferazione, differenziazione e risposte allo stress. La via di segnalazione MAPK è composta da diversi livelli, tra cui ERK, JNK e p38 MAPK, ciascuno con ruoli distinti nella funzione cellulare. La disregolazione della segnalazione MAPK è collegata al cancro, alle malattie infiammatorie e ai disturbi metabolici. Presso CymitQuimica, offriamo una vasta gamma di inibitori e attivatori delle MAPK per supportare la tua ricerca in biologia cellulare, trasduzione del segnale e meccanismi delle malattie.

Trovati 892 prodotti di "MAPK"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • pan-KRAS-IN-3

    CAS:
    Pan-KRAS-IN-3 (Example 84) is a pan-KRAS inhibitor suitable for cancer research [1].
    Formula:C33H32F3N5O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:587.63
  • SB 203580 sulfone

    CAS:
    <p>SB 203580 sulfone, an analog of the p38 MAP kinase inhibitor SB 203580, inhibits IL-1 production in monocytes and binds competitively with CSAID binding proteins (CSBP), inhibiting stress response signaling. It exhibits an IC50 of 0.2 μM for IL-1 inhibition and 0.03 μM for CSBP-mediated signaling inhibition [1].</p>
    Formula:C21H16FN3O2S
    Colore e forma:Solid
    Peso molecolare:393.43
  • (R)-VX-11e

    CAS:
    (R)-VX-11e is an isomer of VX-11e, a potent and selective ERK2 inhibitor with potential to inhibit tumor growth.
    Formula:C24H20Cl2FN5O2
    Purezza:98.73%
    Colore e forma:Solid
    Peso molecolare:500.35
  • AZ-TAK1

    CAS:
    "AZ-Tak1 inhibits TAK1 kinase (IC50=0.009mM), reduces p38/ERK levels, and induces apoptosis in Mino, SP53, Jeko cells with increasing efficacy at 0.1-0.5mM."
    Formula:C25H28FN7O2
    Colore e forma:Solid
    Peso molecolare:477.53
  • Raf inhibitor 3

    CAS:
    Raf inhibitor 3 (Example 30), a potent inhibitor of both B-Raf and C-Raf, exhibits IC50 values below 15 nM. It is applicable in cancer research studies [1].
    Formula:C18H19FN8O2S
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:430.46
  • HPK1-IN-35

    CAS:
    HPK1-IN-35 is a potent, selective inhibitor of HPK1, demonstrating an IC50 value of 3.5 nM.
    Formula:C30H32N8O3S
    Colore e forma:Solid
    Peso molecolare:584.69
  • Rac1-IN-3

    CAS:
    Rac1-IN-3 (Compound 2) is a Rac1 inhibitor exhibiting an inhibitory concentration 50 (IC50) of 46.1 μM [1].
    Formula:C21H23N7O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:405.45
  • BI-0474

    CAS:
    <p>BI-0474: KRASG12C inhibitor, IC50=7.0 nM, blocks GDP-KRAS/SOS1, anti-tumor in NCI-H358 cells &amp; lung cancer model, for cancer research.</p>
    Formula:C30H37N9O2S
    Purezza:99.61%
    Colore e forma:Solid
    Peso molecolare:587.74
  • (R)-BDP9066

    CAS:
    (R)-BDP9066 blocks MRCK to curb cancer cell spread, aiding research on diseases like cancer.
    Formula:C20H24N6
    Colore e forma:Solid
    Peso molecolare:348.44
  • KRAS G12C inhibitor 59

    CAS:
    KRAS G12C Inhibitor 59 is a compound with anticancer properties.
    Formula:C32H39F6N7O5
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:715.69
  • DT-061

    CAS:
    DT-061 is an orally bioavailable protein phosphatase 2A (PP2A) activator. It could be applied in the therapy of KRAS-mutant and MYC-driven tumorigenesis.
    Formula:C25H23F3N2O5S
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:520.52
  • KRAS G12C inhibitor 16

    CAS:
    KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor.
    Formula:C24H21ClFN3O3
    Purezza:97.84%
    Colore e forma:Solid
    Peso molecolare:453.89
  • BDP8900

    CAS:
    BDP8900: potent, selective MRCK inhibitor; alters cancer cell shape, reduces mobility and invasion.
    Formula:C19H23N5S
    Colore e forma:Solid
    Peso molecolare:353.48
  • KRAS G12C inhibitor 58

    CAS:
    KRAS G12C inhibitor 58 is utilized in cancer research as an inhibitor of the KRAS G12C mutation [1].
    Formula:C51H64ClF4N9O8S
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:1074.62
  • RO4927350

    CAS:
    RO4927350 is a potent, selective MEK1/2 inhibitor, blocking MAPK pathway in vitro/vivo and showing notable antitumor effects.
    Formula:C27H28N4O6S
    Colore e forma:Solid
    Peso molecolare:536.6
  • KRAS G12D modulator-1

    CAS:
    KRAS G12D modulator-1 (compound 6), a potent modulator of KRAS G12D, exhibits IC50 values ranging from 1-10 μM against NEA-G12D, PPI-G12D, and p ERK-AGS, and is
    Formula:C30H36FN5O4
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:549.64
  • pan-KRAS-IN-2

    CAS:
    Pan-KRAS-IN-2 (compound 6) is a broad-spectrum KRAS inhibitor exhibiting potent activity with IC50 values of ≤10 nM against KRAS wild type and its mutants (G12D
    Formula:C34H34F2N4O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:584.66
  • SB-682330A

    CAS:
    SB-682330A is a Raf kinase inhibitor.
    Formula:C28H27N3O3
    Colore e forma:Solid
    Peso molecolare:453.53
  • Cobimetinib racemate

    CAS:
    Cobimetinib racemate (Cobimetinib (racemate)) (GDC-0973 racemate) is a selective inhibitor of MEK.Cobimetinib racemate is also known as a mitogen-activated
    Formula:C21H21F3IN3O2
    Purezza:98.00% - 99.71%
    Colore e forma:Solid
    Peso molecolare:531.31
  • KRAS G12C inhibitor 17

    CAS:
    KRAS G12C inhibitor 17 is a potent KRAS G12C inhibitor.
    Formula:C24H20ClF2N3O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:471.88